|

Regeneron Pharmaceuticals Inc ($REGN) more upside in store

The next entry in the theme of Corona Virus stocks is Regeneron Pharmaceuticals Inc.  Regeneron is a Nasdaq-100 component, and has been one of the blue chips of Biotech for some time.  However, the outbreak has really given Regeneron the boost it needs to break out and continue its long term trend.  It remains very technical as with all other stocks that we cover.  So lets take a look at what they do as a company:

“Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.”

Regeneron Monthly Elliott Wave

Chart

In the long term view from 12/01/1994 lows of 3.00. Blue (I) was set at 24.88, and Blue (II) in a flat structure at at 5.60 in April 2005.  After that, Regeneron has proposed to have set Red III of Blue (IV) at 605.93 in August 2015.  After that, Red IV is proposed ended at 271.37 in September of 2019.  Therefore, it is favoured that REGN is advancing in Red V of Blue (III).  There is a long term trend at play here, with more upside favoured to take place.

Regeneron Daily Elliott Wave View

Chart

From the Red IV Low, REGN is favoured to be triple nesting.  However, if Blue (2) low 507.69 gets invalidated, then a larger flat for blue (2) will be favoured instead of a nesting Red 2.  While above 424.01, more upside is favoured to take place into the blue box extreme.

Risk Management

Using proper risk management is absolutely essential when trading or investing in a volatile stocks.  However, Elliott Wave counts can evolve quickly, be sure to have your stops in and define your risk when trading.

Author

Elliott Wave Forecast Team

Elliott Wave Forecast Team

ElliottWave-Forecast.com

More from Elliott Wave Forecast Team
Share:

Editor's Picks

EUR/USD hovers around nine-day EMA above 1.1800

EUR/USD remains in the positive territory after registering modest gains in the previous session, trading around 1.1820 during the Asian hours on Monday. The 14-day Relative Strength Index momentum indicator at 54 is edging higher, signaling improving momentum. RSI near mid-50s keeps momentum balanced. A sustained push above 60 would firm bullish control.

GBP/USD holds medium-term bullish bias above 1.3600

The GBP/USD pair trades on a softer note around 1.3605 during the early European session on Monday. Growing expectation of the Bank of England’s interest-rate cut weighs on the Pound Sterling against the Greenback. 

Gold eyes acceptance above $5,000, kicking off a big week

Gold is consolidating the latest uptick at around the $5,000 mark, with buyers gathering pace for a sustained uptrend as a critical week kicks off. All eyes remain on the delayed Nonfarm Payrolls and Consumer Price Index data from the United States due on Wednesday and Friday, respectively.

Top Crypto Gainers: Aster, Decred, and Kaspa rise as selling pressure wanes

Altcoins such as Aster, Decred, and Kaspa are leading the broader cryptocurrency market recovery over the last 24 hours, as Bitcoin holds above $70,000 on Monday, up from the $60,000 dip on Thursday.

Weekly column: Saturn-Neptune and the end of the Dollar’s 15-year bull cycle

Tariffs are not only inflationary for a nation but also risk undermining the trust and credibility that go hand in hand with the responsibility of being the leading nation in the free world and controlling the world’s reserve currency.

Bitcoin, Ethereum and Ripple consolidate after massive sell-off

Bitcoin, Ethereum, and Ripple prices consolidated on Monday after correcting by nearly 9%, 8%, and 10% in the previous week, respectively. BTC is hovering around $70,000, while ETH and XRP are facing rejection at key levels. Traders should be cautious: despite recent stabilization, upside recovery for these top three cryptocurrencies is capped as the broader trend remains bearish.